The MIND Clinic for Mood and Personality Disorders

Directed by Dr. M. Elizabeth Sublette, Leader of Conte Center Clinical Evaluation Core 2, the MIND Clinic is dedicated to caring for patients and healthy volunteers enrolling in our research studies on mood disorders (major depression and bipolar disorder), borderline personality disorder, and the prevention of suicide and self-injury.

Our staff consists of research psychiatrists and psychologists with expertise in the assessment, diagnosis and treatment of these conditions, and research coordinators who facilitate the interactions between each participant and the MIND team. We strive to combine research into better ways of treating mood disorders and preventing suicidal behavior with optimal clinical care.

Professional Resources for Clinicians and Researchers

Click here for access to the Columbia University Department of Psychiatry and New York State Psychiatric Institute’s weekly  Online Videos from Adult and Child Psychiatry Grand Rounds, and Gender, Sexuality and Health Division Grand Rounds.

Among shared resources we have developed, the Columbia-Suicide Severity Rating Scale (C-SSRS) has been translated into over 90 languages; multiple adaptations for specific situations and populations are available free of charge to all clinicians and investigators through the Columbia Lighthouse Project.

We have also developed and make available methodology for candidate gene assays, cerebrospinal fluid assays, and toxicology that are available to other research groups.

Faculty in our division have international reputations and recognition for their research work and publish their research findings in leading research journals, including Biological PsychiatryThe American Journal of Psychiatry and the Journal of the American Medical Association: Psychiatry, and at national and international conferences, including those of The American Psychiatric AssociationThe Society of Biological PsychiatryThe American College of Neuropsychopharmacology ) and The Society for Neuroscience.

Our work with ketamine and suicide risk has been featured as well in the popular press, e.g. in Bloomberg Businessweek.

Other ongoing studies include fMRI studies through the SCAN lab headed by Dr. Kevin Ochsner and an MRI study of grief: under the direction of Dr. Noam Schneck.

Resources on Depression and Suicide Prevention for the Public


Borderline Personality Disorder

Bipolar Disorder

Suicide Prevention

Organizations Devoted to Depression and Suicide Research

Our Institution